What is the diagnostic approach for non‑obstructive azoospermia in a man with testicular volume <12 mL who has completed genetic counseling?

Diagnostic Approach for Non-Obstructive Azoospermia

In a man with testicular volume <12 mL and completed genetic counseling, non-obstructive azoospermia (NOA) is diagnosed through a systematic evaluation combining semen analysis with centrifugation, hormonal assessment (FSH, testosterone, LH), and consideration of testicular biopsy when clinical parameters are equivocal.

Initial Diagnostic Steps

Semen Analysis Confirmation

• Obtain at least 2 semen analyses one month apart to confirm azoospermia 1
• The laboratory must centrifuge the ejaculate and re-examine the pellet under wet mount microscopy for rare sperm 1
• Document semen volume and pH to help differentiate from obstructive causes

Clinical Differentiation from Obstructive Azoospermia

Key distinguishing features for NOA:

• Testicular atrophy (volume <12 mL, as in your patient) 1
• Elevated FSH >7.6 IU/L 1
• Normal semen volume and pH (>7.0) - rules out distal obstruction 1
• Soft testes on palpation 2
• Absence of epididymal dilatation or induration 1

The combination of atrophic testes with FSH >7.6 IU/L strongly indicates NOA with 89% accuracy 3. Your patient's testicular volume <12 mL already suggests NOA.

Hormonal Workup

Mandatory testing includes:

• FSH - typically elevated in NOA (>7.6 IU/L) 4, 1
• Testosterone - assess for hypogonadism 4
• LH - evaluate hypothalamic-pituitary-gonadal axis 4

Important caveat: FSH levels do not accurately predict the presence of residual spermatogenesis in NOA patients undergoing testicular sperm extraction (TESE), as men with maturation arrest can have normal FSH 4. Emerging evidence suggests anti-Müllerian hormone (AMH) levels may better predict sperm retrieval success, with lower preoperative AMH associated with higher retrieval rates 4.

Genetic Testing (Already Completed in Your Patient)

Since your patient has completed genetic counseling, confirm the following tests were performed:

Mandatory Genetic Tests for NOA:

• Karyotype analysis - identifies chromosomal abnormalities (Klinefelter syndrome most common) 4, 1
• Y-chromosome microdeletion testing - mandatory for azoospermia 4, 1

Critical prognostic information:

• Complete AZFa or AZFb deletions predict poor TESE outcomes; sperm retrieval should not be attempted 4
• AZFc deletions allow successful sperm retrieval in 53-75% of cases 4
• Klinefelter syndrome allows sperm retrieval in 20-50% of cases 4

Imaging Considerations

Scrotal Ultrasound Indications

While physical examination with Prader orchidometer is usually sufficient 4, scrotal ultrasound is valuable in your patient with small testes (<12 mL) for:

• Precise testicular volume measurement when testes are small 4
• Assessment of testicular architecture - non-homogeneous patterns and microcalcifications suggest testicular dysgenesis 4
• Detection of testicular tumors - infertile men are at higher risk 4
• Evaluation of epididymal abnormalities - though less relevant with confirmed small testes 5

Ultrasound showing epididymal abnormalities has 82% sensitivity and 100% specificity for obstructive azoospermia 5, but your patient's small testicular volume already strongly suggests NOA.

Testicular Biopsy Decision Algorithm

When Biopsy is NOT Needed:

Your patient likely falls into this category - with testicular volume <12 mL and presumed elevated FSH, NOA diagnosis is clinical 3. Isolated diagnostic biopsy is rarely indicated 3.

When Biopsy May Be Considered:

In the uncommon scenario where FSH is normal (<7.6 IU/L) despite small testes, creating diagnostic uncertainty between obstructive and non-obstructive causes 6, 7:

• Therapeutic approach: Proceed directly to testicular sperm extraction (cTESE) under anesthesia, progressing to microdissection TESE (microTESE) if needed 6
• This avoids multiple procedures and allows immediate sperm cryopreservation if found 6
• Note: Over two-thirds of men with FSH <7.6 IU/L and unclear clinical indicators actually have NOA on histology 6

Histological Patterns in NOA

If biopsy is performed, expect one of these patterns:

• Sertoli cell-only syndrome (SCOS) - complete absence of germ cells
• Maturation arrest - spermatogenesis halts at specific stage
• Hypospermatogenesis - reduced but present spermatogenesis
• Tubular atrophy - complete testicular failure

Clinical pearl: Normogonadotropic NOA (normal FSH with NOA) represents a distinct subgroup where spermatogenesis fails primarily at the post-meiotic level, with better sperm retrieval rates than hypergonadotropic NOA 7.

Summary Algorithm for Your Patient

Given testicular volume <12 mL:

1. Confirm azoospermia with 2 centrifuged semen analyses
2. Measure FSH, testosterone, LH
3. If FSH >7.6 IU/L: NOA diagnosis is confirmed clinically - no biopsy needed 3
4. If FSH ≤7.6 IU/L: Rare scenario requiring scrotal ultrasound to evaluate for obstruction; if no obstruction found, proceed to therapeutic TESE/microTESE 6
5. Review genetic testing to determine TESE candidacy (avoid if AZFa/AZFb complete deletions) 4
6. Consider AMH testing if available to predict TESE success 4

The diagnosis of NOA in your patient is primarily clinical and does not require invasive testicular biopsy in most cases.